Tricore INC.

Tricore INC. was paid $35.84M by Medicaid between Jul 2022 and Dec 2024, across 310 billing codes. Its largest line is 80050, General health panel — 7.9% of everything it billed.

33Billing provider infoTRICORE INC.
ALBUQUERQUE, NM 87102

33aNPI1841962289assigned 10/04/2021

33bProvider typeClinical Medical Laboratory

28Total paid$35.84M

24GClaims1,842,696

24DCodes billed310

24AFirst – last monthJul 2022 – Dec 2024

Compared with peers

Next to other Clinical Medical Laboratory providers in New Mexico

Rank by total paid#3 of 11

Median peer was paid$1.26M

This provider vs. median28×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2022	366,390	$6.80M
2023	777,341	$15.19M
2024incomplete	698,965	$13.84M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
80050	General health panel	7.9%	57,698	57,214	$2.83M
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	4.8%	56,897	56,262	$1.70M
81513		4.0%	11,500	11,189	$1.43M
80061	Lipid panel	3.8%	101,455	100,287	$1.36M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	3.7%	36,561	35,679	$1.34M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	3.7%	36,574	35,691	$1.34M
88305	Level IV - Surgical pathology, gross and microscopic examination	3.2%	12,849	12,217	$1.16M
80053	Comprehensive metabolic panel	3.2%	111,436	104,917	$1.15M
36415	Collection of venous blood by venipuncture	3.2%	156,060	144,386	$1.14M
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	2.9%	2,430	2,395	$1.05M
84443	Thyroid stimulating hormone (TSH)	2.7%	59,715	58,628	$957K
83036	Hemoglobin; glycosylated (A1C)	2.4%	89,597	88,452	$870K

298 more codes

87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	2.2%	32,597	$805K
88307		2.0%	2,946	$699K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.8%	86,840	$644K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	1.7%	5,240	$617K
80074		1.4%	10,748	$518K
84439		1.4%	56,589	$513K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	1.4%	7,779	$500K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	1.3%	13,218	$484K
86780		1.3%	32,990	$477K
87481		1.2%	11,533	$423K
84403		1.0%	13,432	$368K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	9,869	$357K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	12,260	$335K
82728		<1%	24,255	$332K
86803		<1%	22,680	$328K
82607		<1%	21,589	$326K
82670		<1%	8,135	$321K
87086	Culture, bacterial; quantitative colony count, urine	<1%	38,185	$315K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	4,325	$311K
84481		<1%	16,638	$287K
87902		<1%	974	$260K
88342		<1%	3,007	$256K
86480		<1%	3,926	$245K
85027		<1%	38,251	$242K
87522	Neg quan hep c or qual rna	<1%	5,357	$233K
84270		<1%	9,321	$213K
83550		<1%	23,661	$206K
88341		<1%	1,256	$202K
87505		<1%	1,657	$201K
83970		<1%	5,479	$200K
86003		<1%	1,967	$192K
82746		<1%	12,984	$191K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	4,470	$173K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	4,547	$171K
84153		<1%	9,532	$168K
83540		<1%	25,943	$168K
83001		<1%	8,795	$167K
87653		<1%	4,340	$159K
87340		<1%	14,225	$153K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	1,015	$139K
86376		<1%	8,935	$136K
82570		<1%	25,768	$135K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	1,011	$134K
86038		<1%	10,850	$132K
81511		<1%	896	$129K
86235		<1%	1,785	$126K
88185		<1%	444	$121K
87077		<1%	13,207	$121K
81420	Fetal chromosomal aneuploidy genomic sequence analysis panel	<1%	217	$117K
88360		<1%	544	$113K
84702		<1%	7,078	$110K
88304		<1%	2,897	$110K
83880		<1%	2,914	$108K
86762		<1%	7,073	$106K
82043		<1%	18,816	$103K
88312		<1%	814	$97K
84144		<1%	4,476	$96K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	4,055	$96K
87486		<1%	2,643	$95K
87581		<1%	2,645	$95K
84480		<1%	6,517	$93K
84146		<1%	4,589	$92K
86140		<1%	17,582	$90K
87186		<1%	9,448	$87K
83002		<1%	4,542	$87K
86147		<1%	1,101	$82K
81514		<1%	390	$80K
86787		<1%	5,860	$80K
86146		<1%	1,028	$77K
80048	Basic metabolic panel (calcium, ionized)	<1%	9,474	$77K
86850		<1%	7,507	$76K
82105		<1%	4,224	$72K
86706		<1%	6,204	$70K
86696		<1%	3,174	$61K
81001		<1%	19,275	$59K
83735		<1%	8,595	$58K
82671		<1%	1,195	$55K
82784		<1%	4,688	$53K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	361	$53K
82274		<1%	3,135	$50K
86704		<1%	3,941	$50K
86160		<1%	2,120	$50K
85652		<1%	17,999	$48K
84425		<1%	1,256	$47K
87338		<1%	3,208	$47K
88313		<1%	446	$47K
87536		<1%	554	$46K
86431		<1%	8,077	$46K
85060		<1%	1,940	$46K
86200		<1%	3,243	$43K
86258		<1%	3,813	$43K
82627		<1%	1,881	$42K
80076		<1%	4,968	$41K
86364		<1%	3,831	$40K
86695		<1%	3,069	$40K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	829	$40K
86694		<1%	1,119	$40K
83525		<1%	3,302	$39K
80069		<1%	5,074	$37K
87529		<1%	900	$37K
82626		<1%	732	$37K
83690		<1%	4,217	$35K
83521		<1%	1,318	$35K
83520		<1%	461	$34K
84550		<1%	7,818	$34K
88173		<1%	287	$34K
88141		<1%	1,524	$34K
88112		<1%	829	$33K
83516		<1%	792	$32K
88302		<1%	1,014	$32K
84436		<1%	4,698	$32K
86665		<1%	915	$32K
86800		<1%	1,934	$31K
82248		<1%	6,210	$31K
82533		<1%	1,691	$31K
86708		<1%	2,404	$31K
84156		<1%	8,727	$31K
82024		<1%	752	$29K
85610		<1%	6,734	$29K
84154		<1%	1,603	$29K
82951		<1%	2,088	$28K
87081		<1%	4,053	$28K
85390		<1%	1,012	$27K
83498		<1%	612	$27K
83655		<1%	2,060	$27K
86225		<1%	1,978	$27K
82785		<1%	1,518	$26K
88184		<1%	461	$26K
88189		<1%	369	$24K
82397		<1%	1,562	$23K
87070		<1%	2,638	$23K
82378		<1%	1,239	$23K
86900		<1%	7,358	$22K
86901		<1%	7,322	$22K
81003		<1%	10,031	$22K
86304		<1%	1,093	$22K
80197		<1%	1,748	$22K
83615		<1%	3,629	$22K
81508		<1%	423	$21K
80164		<1%	1,493	$21K
G0452	Molecular pathology procedure; physician interpretation and report	<1%	728	$21K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	451	$21K
84630		<1%	592	$20K
82950		<1%	3,883	$19K
84207		<1%	444	$19K
85730		<1%	3,198	$19K
86334		<1%	961	$19K
84445		<1%	319	$18K
86039		<1%	1,590	$18K
82150		<1%	2,618	$17K
86141		<1%	1,304	$17K
82525		<1%	532	$17K
84482		<1%	390	$17K
82140		<1%	1,168	$16K
84100		<1%	3,712	$16K
86593		<1%	3,484	$16K
82977		<1%	2,041	$16K
84460		<1%	2,917	$15K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	716	$14K
82565		<1%	2,968	$14K
82247		<1%	2,917	$14K
84450		<1%	2,875	$14K
83993		<1%	707	$14K
G0145	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision	<1%	756	$14K
82550		<1%	2,077	$14K
84165		<1%	1,458	$14K
86341		<1%	165	$13K
83090		<1%	725	$13K
86705		<1%	1,044	$13K
81374		<1%	176	$12K
86381		<1%	479	$12K
84681		<1%	575	$12K
88311		<1%	735	$11K
83921		<1%	512	$11K
87205		<1%	2,583	$11K
85613		<1%	1,128	$11K
82040		<1%	2,190	$11K
82653		<1%	215	$10K
85379		<1%	947	$10K
87075		<1%	1,035	$9K
82542		<1%	131	$9K
80178		<1%	1,470	$9K
82390		<1%	797	$9K
81025		<1%	951	$9K
82330		<1%	623	$8K
88331		<1%	68	$8K
85046		<1%	1,388	$8K
86036		<1%	678	$7K
87076		<1%	729	$6K
82731		<1%	100	$6K
88309		<1%	25	$6K
83020		<1%	354	$6K
80177		<1%	478	$6K
82652		<1%	126	$6K
86300		<1%	336	$6K
87497		<1%	137	$6K
84466		<1%	443	$6K
86256		<1%	462	$6K
82103		<1%	349	$6K
86015		<1%	528	$5K
86664		<1%	329	$5K
83789		<1%	56	$5K
86765		<1%	376	$5K
82166		<1%	205	$5K
87799		<1%	118	$4K
86663		<1%	329	$4K
81270		<1%	59	$4K
88300		<1%	268	$4K
86735		<1%	311	$4K
84305		<1%	195	$4K
83519		<1%	39	$4K
81206		<1%	27	$4K
86689		<1%	208	$4K
86060		<1%	499	$4K
84484		<1%	296	$4K
82952		<1%	873	$4K
84590		<1%	149	$4K
84166		<1%	200	$3K
85732		<1%	439	$3K
88142		<1%	144	$3K
88365		<1%	27	$3K
82239		<1%	72	$3K
86632		<1%	45	$3K
86769		<1%	80	$3K
86709		<1%	278	$3K
85018		<1%	1,287	$3K
84432		<1%	52	$3K
86631		<1%	45	$3K
84520		<1%	774	$2K
82668		<1%	127	$2K
80165		<1%	97	$2K
87517		<1%	59	$2K
82947		<1%	707	$2K
84155		<1%	838	$2K
86644		<1%	102	$2K
G0124	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician	<1%	66	$2K
82530		<1%	35	$2K
84134		<1%	137	$2K
85014		<1%	743	$2K
80175		<1%	134	$2K
86361		<1%	58	$2K
84132		<1%	517	$2K
G0475	Hiv antigen/antibody, combination assay, screening	<1%	138	$2K
86645		<1%	84	$1K
88344		<1%	16	$1K
82610		<1%	24	$1K
80156		<1%	105	$1K
86308		<1%	252	$1K
82360		<1%	51	$1K
84300		<1%	243	$1K
87535		<1%	13	$1K
83883		<1%	39	$1K
86008		<1%	13	$968.40
85306		<1%	55	$848.88
83721		<1%	69	$815.34
86301		<1%	40	$812.54
87209		<1%	46	$780.89
82310		<1%	281	$774.45
87147		<1%	84	$746.76
82172		<1%	12	$695.53
85660		<1%	138	$686.69
84446		<1%	26	$670.50
87449		<1%	40	$629.39
82164		<1%	12	$621.54
86870		<1%	40	$573.03
85303		<1%	43	$559.91
84080		<1%	15	$519.79
83695		<1%	15	$519.28
84478		<1%	112	$502.74
87102		<1%	59	$500.34
86255		<1%	28	$488.32
85300		<1%	39	$477.23
82374		<1%	221	$469.30
85384		<1%	56	$462.21
82435		<1%	219	$436.31
87206		<1%	79	$433.50
86778		<1%	13	$426.71
87177		<1%	46	$386.85
84075		<1%	212	$379.39
88291		<1%	13	$343.68
86618		<1%	12	$324.76
G0123	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision	<1%	12	$291.72
84295		<1%	220	$265.57
86880		<1%	43	$249.48
82232		<1%	13	$234.70
87040		<1%	18	$199.80
82272		<1%	42	$185.69
82985		<1%	12	$171.53
81002		<1%	37	$149.41
82553		<1%	12	$109.02
80185		<1%	13	$104.03
82575		<1%	12	$102.75
82465		<1%	24	$94.20
82340		<1%	13	$60.69
81050		<1%	12	$52.44
G0328	Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous	<1%	13	$16.97
G0499	Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result	0%	50	$0.00
76098		0%	58	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWATT, ELLA (CHIEF FINANCIAL OFFICER)